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Combinatorial biosynthesis of ‘unnatural’ natural products: 
the polyketide example 
Multi-enzyme systems, such as those involved in the biosynthesis of polyketides, 
typically catalyze several distinct reactions that are combined in different ways 
to generate diverse natural products. The variability available in such systems 
has not been fully harnessed from nature. It may therefore be possible to 
create ‘unnatural’ natural products, which may be as structurally 
diverse and medicinally valuable as existing natural products, 
using combinatorial biosynthesis. 
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Nature excels in the combinatorial biosynthesis of poly- 
functional organic molecules.This was perhaps first recog- 
nized over a century ago, when Collie [l] suggested that 
many structurally diverse natural products might arise 
from multiple two-carbon condensation reactions. He 
called this class of natural products the ‘polyketides’ [2]. 
The discovery and analysis of the multi-enzyme systems 
that catalyze the polymerization, cyclization and tailoring 
of polyketides to a specific function has occupied many of 
the intervening decades. 
Today, the understanding of polyketide biosynthesis has 
reached a point where we can now contemplate the idea 
of adapting the system to our own ends.The prospect of 
genetically manipulating polyketide biosynthesis to gen- 
erate libraries of ‘unnatural’ natural products is no longer 
within the realm of fantasy. In this review, we evaluate 
recent progress in generating novel polyketide products, 
and the strategies suggested by these recent successes for 
the combinatorial generation of molecular diversity. 
There are at least two good reasons for wishing to 
manipulate natural product synthesis in this way. First, 
such exercises can yield new insight into the function 
and mechanisms of enzymes involved in natural product 
biosynthesis. Second, libraries produced in this way 
would offer unique opportunities for drug discovery 
and development, since they combine the power of 
combinatorial chemistry with the proven track record of 
natural products as human therapeutic, veterinary and 
agrochemical agents. 
Here we focus primarily on the class of polyketides for 
which most information is currently available, the bacter- 
ial aromatic polyketides. It is to be hoped that this type of 
analysis will soon also be possible for more complex 
polyketide pathways, such as those responsible for the 
synthesis of macrolides. Although the knowledge database 
for these pathways is relatively rudimentary, available 
insights from directed mutagenesis studies in these 
systems suggest that their potential for combinatorial 
biosynthesis could be substantially greater.We therefore 
provide a brief analysis of the overall functional plasticity 
in complex polyketide pathways. Even the complex 
polyketides are only the beginning, however; we speculate 
that there may be considerable combinatorial potential 
within other families of natural products. 
Polyketide biosynthesis 
The chemistry and biology of polyketide biosynthesis 
have been the subjects of several excellent reviews 
within the past three years [3-61. Polyketides are a large 
family of structurally diverse natural products possessing 
a wide range of biological activities, including anti- 
biotic and other pharmacological properties. They are 
synthesized by multifunctional polyketide synthase 
enzymes (PKSs). PKSs catalyze repeated condensation 
cycles between acyl thioesters (usually acetyl, propionyl, 
malonyl or methylmalonyl). Each cycle results in the 
formation of a p-keto group that may undergo all, part, 
or none of a series of reductive steps (Fig. 1). In the case 
of aromatic PKSs, the P-keto groups are left largely 
unmodified and the resulting highly reactive polyke- 
tide backbone undergoes a series of enzyme-catalyzed 
regiospecific cyclizations. 
Types of PKSs 
Over the past decade, cloning and sequence analysis of 
PKS genes have defined two types of PKSs (Fig.2). 
Complex or ‘modular’ PKSs, which catalyze the biosyn- 
thesis of macrolides such as erythromycin, are assemblies 
of large multifunctional proteins, with a different active 
site for each enzyme-catalyzed step in carbon-chain 
assembly and modification [7]. The active sites are clus- 
tered into modules, so that each module contains all the 
different sites required for one cycle in the iterative con- 
densation process (Fig. 1). Once the product has gone 
through one cycle, for example the four-carbon to six- 
carbon condensation step for acetyl thioesters, it moves 
to the next enzyme module, which contains the active 
sites responsible for the six-carbon to eight-carbon con- 
densation step. In contrast, the PKSs responsible for the 
0 Current Biology Ltd ISSN 1074-5521 355 
356 Chemistry & Biology 1995, Vol 2 No 6 
KS G-SH 
R2 
t KR 
R2 
t DH 
A,$-s+R1 
R2 
9 
KS <-s-I’ 
‘/ A&H 
Fig. 1. Catalytic cycle for polyketide 
backbone biosynthesis. Biosynthesis of 
the carbon-chain backbone of a poly- 
ketide involves the following enzyme- 
catalyzed reactions. At the start of any 
condensation cycle, the growing poly- 
ketide chain is attached via a thioester 
linkage to a cysteine residue in the 
active site of the ketosynthase (KS). An 
acyltransferase (AT) transfers the car- 
boxylated extender unit from CoA to the 
4’ phosphopantetheine arm of the acyl 
carrier protein (ACP). The choice of the 
extender (R,) is presumably dictated by 
the specificity of the AT. Following a 
condensation catalyzed by the KS, the 
P-carbonyl in the nascent chain can be 
subjected to all, part, or none of a series 
of steps catalyzed by a ketoreductase 
(KR), dehydratase (DH), and enoyl- 
reductase (ER). After the chain has been 
through a fixed number of condensation 
cycles, it is released from the PKS via 
the action of a thioesterase (TE). 
Wherever applicable, the stereochem- 
istry at any asymmetric center is 
uniquely controlled by the PKS. 
Polyketide 
biosynthesis of aromatic polyketides, such as 6-methyl- 
salicylic acid and actinorhodin, generate the entire 
carbon-chain backbone using a single set of iterative 
active sites (Fig. 2). These active sites can perform the 
reactions required to add an extra acyl unit to a wide 
range of substrates of different chain length, and perform 
such additions repeatedly until the backbone reaches the 
length required. 
Iterative PKSs can exhibit considerable architectural 
variety. For example, bacterial aromatic PKSs, such as 
the actinorhodin PKS, are made up of several distinct 
polypeptide subunits, each containing one or two active 
sites. In contrast, fungal PKSs such as the 6-methyl- 
salicylic acid PKS consist of a single multi-domain 
polypeptide which includes all the active sites required 
for the biosynthesis of 6-methylsalicylic acid. In some 
cases, the nascent polyketide chain undergoes subse- 
quent cyclizations and other regiospecific modifications. 
Some of these steps may also be catalyzed by the PKSs 
themselves. Although the combinatorial biosynthesis 
potential in modular PKSs may be greater, as the itera- 
tive PKSs are smaller they have been more convenient 
targets for manipulation thus far. 
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Fig. 2. Polyketide synthase gene clusters. 
The gene clusters encoding three repre- 
sentative gene clusters are schematically 
shown. The 6-MSAS gene cluster from 
Penicillium patulum encodes a multi- 
functional protein responsible for the 
synthesis of 6-methylsalicylic acid. The 
act gene cluster from Streptomyces 
coelicolor encodes a multi-subunit PKS 
responsible for the biosynthesis of the 
bicyclic precursor of actinorhodin (Fig. 
4). The ery gene cluster from Saccharo- 
polyspora erythraea encodes three large 
multifunctional proteins that catalyze 
the biosynthesis of 6-deoxyerythronolide 
B, a precursor of erythromycin (see Fig. 
6). Each shaded region is indicative of a 
putative active site domain identified 
either via mutagenesis or through 
sequence comparison with enzymes 
having known functions. For further 
details on the functions of these active 
sites, see text or Figure 1 legend. 
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Genetic construction of combinatorial PKS libraries 
To explore the combinatorial potential in PKSs, a 
multi-disciplinary strategy for the engineered biosyn- 
thesis of novel natural products was recently developed 
[8]. The strategy involves a host-vector system capable 
of high-level expression of subsets of biosynthetic 
genes. The heterologous host, Streptomyces coelicolor 
CH999, contains a chromosomal deletion of the entire 
act gene cluster, which encodes the biosynthesis of the 
aromatic polyketide actinorhodin. Shuttle plasmids are 
used to express recombinant PKSs in CH999. Such 
plasmids typically include a colEI replicon, an appropri- 
ately truncated SCP2* Streptomyces replicon, two uct- 
promoters to allow for bidirectional cloning, the gene 
encoding the actII-ORF4 activator which induces tran- 
scription from act promoters during the transition from 
growth phase to stationary phase, and appropriate 
marker genes. Restriction endonuclease cleavage sites 
have been engineered into these vectors to facilitate the 
combinatorial construction of PKS gene clusters start- 
ing from cassettes encoding individual subunits (or 
domains) of naturally occurring PKSs. 
The primary advantages of the above strategy are that (i) 
all relevant biosynthetic genes are plasmid-borne and 
therefore are amenable to facile manipulation and muta- 
genesis in Escherichia coli; (ii) the entire library of PKS 
gene clusters is expressed in the same bacterial host 
which is genetically and physiologically well character- 
ized and presumably contains most, if not all, ancillary 
activities required for in viva production of polyketides; 
(iii) polyketides are produced only after log-phase 
growth, alleviating the toxic effects of synthesizing 
potentially bioactive cornpounds in viva; and (iv) mole- 
cules produced in this manner undergo fewer side reac- 
tions than if the same pathways were expressed in 
wild-type organisms or in mutants in which the natu- 
rally occurring pathway is blocked at a particular step. 
This system has been successfully used to express func- 
tional, recombinant aromatic PKSs and produce several 
novel aromatic polyketides [8-171. To extrapolate this 
technology to larger gene clusters (such as the modular 
PKSs), an in viva recombination strategy has been devel- 
oped for the design and construction of plasmids con- 
taining more than 20 kb of PKS gene sequence [18]. 
Fig. 3. Overall biosynthetic pathway for 
a typical polyketide natural product. A 
typical polyketide pathway can be 
thought of as occurring in three stages. 
In the first stage, catalyzed by the PKS, a 
nascent polyketide backbone is gener- 
ated from monomeric CoA thioesters. In 
the second stage, this backbone is 
regiospecifically cyclized. While some 
cyclization reactions are controlled by 
the PKS itself, others are performed by 
downstream enzymes. In the final stage, 
the cyclized intermediate is modified 
further by the action of mechanistically 
diverse ‘tailoring enzymes’, giving rise 
to the natural product. 
Aromatic polyketide biosynthetic pathways 
As a prerequisite for combinatorial biosynthesis, it is nec- 
essary to elucidate the functions and specificities of 
various enzymes in naturally occurring aromatic polyke- 
tide pathways. A typical pathway for polyketide biosyn- 
thesis is schematically outlined in Figure 3. Figure 4 
shows the steps involved in the biosynthesis of a repre- 
sentative aromatic polyketide, actinorhodin. Polyketide 
biosynthesis begins with the loading of a primer unit 
into the active site of the condensing enzyme, P-keto 
acyl synthase (KS; Fig. 2). An extender unit (usually mal- 
onate) is then transferred to the pantetheinyl arm of the 
acyl carrier protein (ACP; Fig. 2), and the KS catalyzes 
the condensation between the ACP-bound malonate and 
the starter unit. Additional extender units are added 
sequentially until the nascent polyketide chain has grown 
to a desired chain length determined by the protein 
chain length factor (CLF; Fig. 2), perhaps together with 
the KS.Thus, the KS, CLF and the ACP form a minimal 
set of proteins necessary to generate a polyketide back- 
bone, and are together called the ‘minimal PKS’ (Fig. 4). 
The nascent polyketide chain is then subjected to 
regiospecific ketoreduction by a ketoreductase (KR; Fig. 
4) if it exists. Cyclases (CYC; Fig. 4) and aromatases 
(ARO; Fig. 4) later catalyze regiospecific ring formation 
events through intramolecular aldol condensations. The 
cyclized intermediate may then undergo additional 
regiospecific and/or stereospecific modifications (e.g. O- 
methylation, hydroxylation, glycosylation) controlled by 
downstream tailoring enzymes (Fig. S).The absence of an 
enzyme activity beyond the minimal PKS typically 
results in the formation of a shunt product. 
Combinatorial potential in aromatic polyketide biosynthesis 
I) From monomers to partially cyclizedpolyketide backbones 
The initial steps in polyketide biosynthesis provide 
several possible ways to modify the synthetic pathway 
that could be exploited to generate structural diversity. 
a. Established degrees of freedom 
Expression and analysis of numerous recombinant bacter- 
ial PKSs has led to significant advances in our under- 
standing of aromatic PKS function and specificity. In 
turn, these insights have led to the proposal of a set of 
design rules for rational or stochastic manipulation of 
Monomers 
Tailoring enzymes 
I 
(oxidoreductases, 
group transferases, 
etc.) 
Polyketide 
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Fig. 4. Biosynthetic pathway for the aromatic polyketide, actinorhodin. The ‘minimal PKS’ (min PKS), composed of a ketosynthase, a 
chain-length factor, and an acyl carrier protein, synthesizes an unreduced octaketide backbone, which is then reduced at the C-V car- 
bony1 by a ketoreductase (KR). The reduced backbone is then cyclized into a bicyclic intermediate through the action of the minimal 
PKS, an aromatase (ARO), and a cyclase (CYC). This intermediate is finally converted into actinorhodin through the action of several 
tailoring enzymes. None of the above intermediates have been directly isolated; the pathway has instead been deduced through an 
analysis of shunt producti isolated from a series of deletion mutants in the PKS gene cluster. 
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early biosynthetic step i in aromatic polyketide pathways, 
including chain synthesis, C-9 ketoreduction, and the for- 
mation of the first two aromatic rings [17]. If each 
biosynthetic degree of freedom was independent of all 
others, then it should be possible to design a single com- 
binatorial library of N, x N, x N, x... clones, where Ni is 
the number of ways in which the ith degree of freedom 
can be exploited, each of which should generate a differ- 
ent polyketide product. In practice, however, not all enzy- 
matic degrees of freedom are independent [17]. 
Therefore, to minimize redundancy, it is preferable to 
design several sub-libraries of aromatic polyketide pro- 
ducing clones. For example, for reduced polyketides, the 
relevant degrees of freedom include the chain length 
(which can be manipulated in seven ways using naturally 
occurring minimal PKSs with different chain-length 
specificities), the first ring aromatization (which gives two 
possible outcomes, aromatized or not), and the second 
ring cyclization (which occurs only after the first ring 
aromatization, so that there are three possible outcomes in 
total). For unreduced polyketides, the regiospecificity of 
the first cyclization can be manipulated (two possibilities) 
in addition to chain length (seven possibilities). Thus, the 
known combinatorial potential is 7 x 3 = 21 for reduced 
chains and 7 x 2 = 14 for unreduced chains. These 
numbers do not include additional minor products, of the 
order of 5 to 10 per major product, that are produced in 
the recombinant strains through non-enzymatic or non- 
specific enzyme catalyzed steps. Thus, the number of 
polyketides that can be generated from combinatorial 
manipulation of only the first few steps in aromatic 
polyketide biosynthesis is of the order of a few hundred. 
It is important to note that, based on limited structural 
analysis of the -25 compounds produced thus far using 
this method, most of the compounds in such libraries are 
likely to be novel chemical entities [8-17].Thus, geneti- 
cally engineered biosynthesis appears to represent an 
untapped source of chemical diversity for drug discovery. 
b. Starter unit 
There are other steps in aromatic polyketide biosynthe- 
sis that are attractive targets for expanding aromatic 
polyketide libraries even further via combinatorial 
manipulation. For example, although acetyl CoA is the 
usual starter unit for most aromatic polyketides, mal- 
oamyl CoA [19] and propionyl CoA [20] are primers 
for many members of the tetracycline and anthracycline 
classes of polyketides, respectively (Fig. 5). Isotope label- 
ing studies have shown that the complete PKS for the 
anthracycline daunorubicin can accept acetate, butyrate, 
and isobutyrate as starter units as well [21,22]. More 
recently, the observation that acetate can also be used as 
a primer by the daunorubicin minimal PKS [23] and by 
the oxytetracycline PKS [14] has provided further evi- 
dence that some PKSs possess relaxed specificity for the 
primer unit. Although the enzymatic basis for non- 
acetate primer incorporation remains obscure, recent 
studies by Hutchinson and coworkers suggest that this 
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Fig. 5. Structures of several polyketide natural products referred to in the text.. 
property may be due to the presence of a specific acyl- 
transferase and/or an additional KS-like protein [24]. If 
these subunits can productively interact with minimal 
PKSs that have other chain length specificities, they 
would be attractive targets for incorporation into the 
above combinatorial format. 
c. Ketoreduction 
The act KR can productively interact with all minimal 
PKSs studied thus far and is both necessary and sufficient 
to catalyze a C-9 ketoreduction. Although homologous 
KRs have been found in other PKS clusters, they catalyze 
ketoreduction with the same regiospecificity and there- 
fore do not provide an additional source of diversity. 
However, the structures of tienolicin, griseusin and 
daunorubicin suggest that an additional C-17 ketoreduc- 
tion occurs in these biosynthetic pathways (Fig. 5). 
Several angucyclines also undergo an additional ketore- 
duction at C-15, before the nascent polyketide chain is 
cyclized [25]. The ketoreductases responsible for C-l 5 or 
C-17 reductions have not yet been identified; however, 
two homologous KR sequences have been found in the 
daunorubicin PKS cluster [26,27]. It is probable that they 
catalyze the C-9 and C-17 reductions.Thus, KRs respon- 
sible for regiospecific reduction of the carbon-chain 
backbone at positions other than C-9 may also be useful 
in the construction of combinatorial libraries. 
I) From partially cyclized polyketide backbones to fully 
cyclized intermediates 
As discussed above, the formation of the first two six- 
membered rings in the biosynthesis of most naturally 
occurring bacterial aromatic polyketides is controlled 
by PKS subunits. Further ring closures are controlled 
by additional cyclases and modifying enzymes. The 
structural diversity introduced through these reactions 
appears to be greater than that for the first two cycliza- 
tions. Certain preferred patterns are observed, however, 
which suggests that at least some of these downstream 
cyclases may be combinatorially useful. For example, 
the pyran ring in isochromanequinones (Fig. 5) invari- 
ably forms via cyclization between C-3 and C-15, and 
two stereochemically distinct classes of products are 
observed (see, for example, the structures of acti- 
norhodin and frenolicin in Fig. 5). In anthracyclines 
and tetracyclines a third aldol condensation usually 
occurs between C-3 and C-16, whereas in unreduced 
tetracenomycins and related compounds it occurs 
between C-5 and C-18, and in angucyclines it occurs 
between C-4 and C-17. Representative genes encod- 
ing a few of these enzymes have already been cloned 
[28,29]. It is possible that at least some cyclases might 
recognize chains of altered lengths and/or degrees of 
reduction, thus increasing the diversity of aromatic 
polyketide combinatorial libraries. 
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In the absence of downstream cyclases, polyketide chains 
undergo non-enzymatic reactions. Recently, some 
degree of predictability has emerged within this reper- 
toire of possibilities as well [ 171. For instance, hemiketals 
and benzene rings are two common moieties seen on 
the methyl end. Hemiketal formation typically involves 
an enol and is then followed by dehydration. Benzene 
rings are formed if the uncyclized methyl terminus of a 
chain consists of more than three ketide units. On the 
carboxyl terminus, a y-pyrone ring formed by three 
ketide units is frequently observed. Spontaneous decar- 
boxylations occur on free carboxyl ends activated by the 
existence of a B-carbonyl. 
111) From cyclized intermediates to natural prodbcts I 
A cyclized intermediate can undergo various types of 
modifications to generate the final natural product. The i 
recurrence of certain structural motifs among naturally 
occurring aromatic polyketides suggests that some tailor- 
ing enzymes, particularly group transferases, may be! 
combinatorially usefulTwo examples are discussed below. 
a. O-methyl transfer 
0-methylation is a common downstream modification. 
Although several S-adenosylmethionine-dependent 
0-methyltransferase genes have been found in PKS 
gene clusters [30], their specificities have not yet been 
systematically studied. Perhaps some of them could be 
useful for combinatorial biosynthesis. For instance, 
O-11 methylation occurs in several members of the 
anthracycline and angucycline classes of aromatic 
polyketides (Fig. 5). Likewise, the 2-hydroxyl-5-methyl- 
benzoic acid moiety of tetracenomycin C is often 
observed in natural and engineered products; the tetra- 
cenomycin 0-methyltransferase should therefore be a 
good candidate for modification of these products. 
b. Glycosyltransfer 
Both aromatic and complex polyketides are often glyco- 
sylated. In many cases (e.g. doxorubicin and erythromycin) 
absence of the sugar group(s) results in considerably weaker 
bioactivity. There is tremendous diversity in both the types 
and numbers of sugar units attached to naturally occurring 
polykende, aglycones, although deoxy- and aminosugars are 
commonly found. Regiochemical preferences can be 
detected in many glycosylated natural products. Among 
anthra 4 clines, O-17 is frequently glycosylated, whereas 
amon angucyclines, C-10 is usually glycosylated. Elegant 
t&l StUdi y Katz and coworkers [7] suggest that the glycosyl- 
transferases involved in erythromycin biosynthesis have 
relaxed specificities for the aglycone moiety. More unusual 
but significant is the recent report by Decker et al. [31] that an 
elloramycin glycosyltransferase may be able to recognize an 
unnatural NDP-sugar unit and attach it regiospecifically to an 
aromatic polyketide aglycone.These early results suggest that 
glycosyltransferases derived from secondary metabolic path- 
ways have unique properties and may be useful in the genera- 
tion of combinatorial libraries.The potential for manipulating 
glycoside biosynthesis is discussed below. 
Combinatorial biosynthesis: beyond bacterial 
aromatic polyketides 
1) Modular polyketide synthases 
Although modular PKSs have not been extensively ana- 
lyzed, the one-to-one correspondence between active 
sites and product structure (Fig. 6), together with the 
incredible chemical diversity observed among naturally 
occurring ‘complex’ polyketides, suggests that the combi- 
natorial potential within these multi-enzyme systems 
could be considerably greater than that for aromatic 
PKSs. For example, a wider range of primer units includ- 
ing aliphatic monomers (acetate, propionate, butyrate, iso- 
valerate, etc.), aromatics (aminohydroxybenzoic acid), 
Module 1 Module 3 Module 5 
/ 
C-Deoxyerythronolide B 
Fig. 6. Biosynthetic pathway for 6-deoxyerythronolide B synthase (DEBS). 6-Deoxyerythronolide B is the macrocyclic precursor of ery- 
thromycin. DEBS is made up of three large multifunctional proteins, each composed of a number of active site domains (abbreviated as 
in Fig. 1). These domains are organized into modules; each module includes all the active sites required for catalyzing a condensation 
reaction, together with associated reductive modifications. Following synthesis of an appropriately reduced heptaketide precursor, the 
chain is regiospecifically cyclized into a 14-membered macrolactone, presumably through the action of the TE. The above pathway has 
been deduced through sequence comparisons with known enzymes and through analysis of a few site-directed mutants. 
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alicyclics (cyclohexanoic acid), and heterocyclics 
(pipecolic acid) are found in various macrocyclic polyke- 
tides. Recent studies have shown that modular PKSs have 
relaxed specificity for their starter units [IS]. The degree 
of P-ketoreduction following a condensation reaction can 
be altered by genetic manipulation [7,32], and the size of 
the polyketide product can also be varied by designing 
mutants with the appropriate number of modules [33]. 
Modular PKSs also exhibit considerable variety with 
regard to the choice of extender units in each condensa- 
tion cycle, although it remains to be seen to what extent 
this property can be manipulated.These enzymes are also 
particularly well known for generating an impressive 
range of asymmetric centers in their products in a highly 
controlled manner, It is therefore tempting to speculate 
that the combinatorial potential within modular PKS 
pathways could be virtually unlimited. 
II) Fungal PKSs 
Like the actinomycetes, filamentous fungi are a rich 
source of polyketide natural products. The fact that 
fungal PKSs, such as the 6-methylsalicylic acid synthase 
(6-MSAS) and the mevinolin synthase, are encoded by 
single proteins having multiple domains ([34] and Davis, 
R. et al., abstract P228 Genetics of Industrial Micro- 
organisms Meeting, Montreal, 1994) suggests that they 
may also be well suited for combinatorial mutagenesis. 
Moreover, functional fimgal PKSs can be expressed in S. 
coelicolor CH999 using the genetic strategy outlined 
above [35]. As yet, no evidence exists for the functional 
plasticity of domains within fungal PKSs; based on a 
comparative analysis of fungal polyketides, however, one 
can speculate on the potential for designing combinator- 
ial libraries using fungal PKSs. For example, chain lengths 
not observed in bacterial aromatic polyketides (e.g. 
tetraketides, pentaketides and hexaketides) can be found 
among fungal aromatic polyketides [3]. The cyclization 
patterns of fungal aromatic polyketides are also quite dif- 
ferent from those observed in bacterial aromatic polyke- 
tides [3]. In contrast with modular PKSs from bacteria, 
branched methyl groups are introduced into fungal 
polyketide backbones by S-adenosylmethionine-depen- 
dent methyltransferases; in the case of the mevinolin 
PKS, this activity is encoded as one domain within a 
monocistronic PKS (Davis, R. et al., as above). It is now 
possible to experimentally evaluate whether these and 
other sources of chemical diversity in fungal polyketides 
are indeed amenable to combinatorial manipulation. 
111) Other families of natural products 
PKSs are probably not unique among natural product 
biosynthetic enzymes in terms of their potential for com- 
binatorial biosynthesis. The biosynthesis of many other 
natural products involves controlled assembly of discrete 
‘building block units’ followed by subsequent cyclization 
and modification reactions. For example, non-ribosomal 
peptides such as gramicidin, enniatin, and cyclosporin 
[36] are also synthesized by multifunctional enzymes con- 
sisting of homologous domains with similar functions but 
different specificities. Similarly, the enzymes involved in 
the biosynthesis of diverse glycosides, such as strepto- 
mycin and the lipopolysaccharide O-chains in Salmonellae 
are also homologous [37]. G’ iven currently available tools 
for facile genetic manipulation, it may soon be possible to 
evaluate whether these pathways are also amenable to the 
‘mix-and-match’ approach. After all, nature’s strategy for 
the evolution of its vast ensemble of structurally intricate 
and pharmaceutically useful organic molecules has been 
precisely that. 
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